达芬奇机器人联合术前滋养血管预栓塞在慢性肺曲霉病外科治疗中的应用

doi:10.19982/j.issn.1000-6621.20240507

摘要/Abstract

摘要：

目的: 通过将术前滋养血管预栓塞与达芬奇机器人手术系统相结合,研究其在慢性肺曲霉病外科治疗中的应用价值。方法: 回顾性分析2022年1月1日至2023年12月31日因慢性肺曲霉病伴咯血于深圳市第三人民医院胸外科行达芬奇机器人手术治疗的7例患者的临床资料,包括性别、年龄、术中出血量、手术时间、术后胸管留置时间、术后住院时间等,分析治疗的效果及安全性。结果: 7例患者中,男性5例,女性2例,平均年龄为(34.2±15.1)岁。7例患者术中均未发生大出血,未中转开胸。平均手术时间为(363.3±196.0)min,平均术中出血量为(127.1±62.4)ml;术后胸管平均留置时间为(9.4±5.8)d。术后平均住院时间为(10.7±6.2)d。结论: 达芬奇机器人手术联合术前滋养血管预栓塞对慢性肺曲霉病的治疗是一种安全有效的方法,未来仍需通过更大样本量的临床研究进行结论验证。

关键词: 曲霉菌病, 机器人, 胸外科手术, 术前预栓塞

Abstract:

Objective: By combining preoperative vascular embolization with the Da Vinci robotic surgical system, study its application value in the surgical treatment of chronic pulmonary aspergillosis. Methods: A retrospective analysis was conducted on clinical data of 7 patients with chronic pulmonary aspergillosis and hemoptysis who underwent Da Vinci robot surgery at Department of Thoracic Surgery, Shenzhen Third People’s Hospital from January 1, 2022 to December 31, 2023. These clinical data included gender, age, intraoperative blood loss, operation time, postoperative chest tube indwelling time, postoperative hospital stay. The therapeutic effect and safety were analyzed. Results: Among the 7 patients, 5 were male and 2 were female, with an average age of (34.2±15.1) years. No major intraoperative bleeding or conversion to open chest surgery occurred. The average surgical duration was (363.3±196.0) minutes, with an average intraoperative blood loss of (127.1±62.4) ml; the mean postoperative chest tube placement duration was (9.4±5.8) days, and the average hospital stay was (10.7±6.2) days. Conclusion: Combining Da Vinci robotic surgery with preoperative nourishing artery embolization is a safe and effective method for treating chronic pulmonary aspergillosis, future clinical studies with larger sample sizes are still needed to validate conclusions.

Key words: Aspergillosis, Robotics, Thoracic surgical procedures, Preoperative nourishing vascular pre-embolization

中图分类号:

R655.3
R81

付强, 施琴朗, 李绍鹏, 周孜孜, 黄丕来, 乔坤. 达芬奇机器人联合术前滋养血管预栓塞在慢性肺曲霉病外科治疗中的应用[J]. 中国防痨杂志, 2025, 47(3): 287-291. doi: 10.19982/j.issn.1000-6621.20240507

Fu Qiang, Shi Qinlang, Li Shaopeng, Zhou Zizi, Huang Pilai, Qiao Kun. Application of Da Vinci robotic surgery combined with preoperative nourishing vascular pre-embolization in the surgical treatment of chronic pulmonary aspergillosis[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 287-291. doi: 10.19982/j.issn.1000-6621.20240507

图/表 4

图1

图4

图5

表1

参考文献 33

[1]	Godet C, Philippe B, Laurent F, et al. Chronic pulmonary aspergillosis: an update on diagnosis and treatment. Respiration, 2014, 88(2): 162-174. doi:10.1159/000362674. pmid: 24943102
[2]	汤韵博, 周楠, 刘云杰, 等. 慢性阻塞性肺疾病患者正五聚蛋白-3基因单核苷酸多态性与肺曲霉菌感染关系及其影响因素分析. 临床军医杂志, 2023, 51(12): 1294-1297. doi:10.16680/j.1671-3826.2023.12.23.
[3]	Barac A, Kosmidis C, Alastruey-Izquierdo A, et al. Chronic pulmonary aspergillosis update: A year in review. Med Mycol, 2019, 57(Supplement_2): S104-S109. doi:10.1093/mmy/myy070.
[4]	Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ, 2011, 89(12): 864-872. doi:10.2471/BLT.11.089441.
[5]	Bongomin F. Post-tuberculosis chronic pulmonary aspergillosis: An emerging public health concern. PLoS Pathog, 2020, 16(8): e1008742. doi:10.1371/journal.ppat.1008742.
[6]	Smith NL, Denning DW. Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J, 2011, 37(4): 865-872. doi:10.1183/09031936.00054810. pmid: 20595150
[7]	El-Baba F, Gao Y, Soubani AO. Pulmonary Aspergillosis: What the Generalist Needs to Know. Am J Med, 2020, 133(6): 668-674. doi:10.1016/j.amjmed.2020.02.025. pmid: 32240631
[8]	Phoompoung P, Chayakulkeeree M. Chronic Pulmonary Aspergillosis Following Nontuberculous Mycobacterial Infections: An Emerging Disease. J Fungi (Basel), 2020, 6(4): 346. doi:10.3390/jof6040346.
[9]	Nam HS, Jeon K, Um SW, et al. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Int J Infect Dis, 2010, 14(6): e479-e482. doi:10.1016/j.ijid.2009.07.011.
[10]	Patterson TF, Thompson GR 3rd, Denning DW, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis, 2016, 63(4): e1-e60. doi:10.1093/cid/ciw326.
[11]	Akbari JG, Varma PK, Neema PK, et al. Clinical profile and surgical outcome for pulmonary aspergilloma: a single center experience. Ann Thorac Surg, 2005, 80(3): 1067-1072. doi:10.1016/j.athoracsur.2005.03.078. pmid: 16122488
[12]	Lee SH, Lee BJ, Jung DY, et al. Clinical manifestations and treatment outcomes of pulmonary aspergilloma. Korean J Intern Med, 2004, 19(1): 38-42. doi:10.3904/kjim.2004.19.1.38. pmid: 15053042
[13]	Shin B, Koh WJ, Shin SW, et al. Outcomes of Bronchial Artery Embolization for Life-Threatening Hemoptysis in Patients with Chronic Pulmonary Aspergillosis. PLoS One, 2016, 11(12): e0168373. doi:10.1371/journal.pone.0168373.
[14]	Setianingrum F, Rautemaa-Richardson R, Shah R, et al. Clini-cal outcomes of patients with chronic pulmonary aspergillosis managed surgically. Eur J Cardiothorac Surg, 2020, 58(5): 997-1003. doi:10.1093/ejcts/ezaa137. pmid: 32386208
[15]	Garvey J, Crastnopol P, Weisz D, et al. The surgical treatment of pulmonary aspergillomas. J Thorac Cardiovasc Surg, 1977, 74(4): 542-547.
[16]	Regnard JF, Icard P, Nicolosi M, et al. Aspergilloma: a series of 89 surgical cases. Ann Thorac Surg, 2000, 69(3): 898-903. doi:10.1016/s0003-4975(99)01334-x. pmid: 10750780
[17]	Brik A, Salem AM, Kamal AR, et al. Surgical outcome of pulmonary aspergilloma. Eur J Cardiothorac Surg, 2008, 34(4): 882-885. doi:10.1016/j.ejcts.2008.06.049. pmid: 18701313
[18]	陈乾坤, 姜格宁, 陈昶, 等. 胸腔镜外科治疗肺曲菌球. 中华胸心血管外科杂志, 2014, 30(2): 98-100. doi:10.3760/cma.j.issn.1001-4497.2014.02.011.
[19]	游佩涛, 刘建雄, 薛宗锡, 等. 157例肺曲霉菌病的外科术式与预后关系分析. 临床肺科杂志, 2018, 23(12): 2183-2186. doi:10.3969/j.issn.1009-6663.2018.12.012.
[20]	李义帅, 秦学博, 李香兰, 等. 电视辅助胸腔镜手术与开胸手术治疗难治性空洞性肺结核的效果分析. 结核与肺部疾病杂志, 2022, 3(4): 292-295. doi:10.19983/j.issn.2096-8493.20220029.
[21]	Yan TD, Black D, Bannon PG, et al. Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer. J Clin Oncol, 2009, 27(15): 2553-2562. doi:10.1200/JCO.2008.18.2733. pmid: 19289625
[22]	Kent MS, Hartwig MG, Vallières E, et al. Pulmonary Open, Robotic, and Thoracoscopic Lobectomy (PORTaL) Study: An Analysis of 5721 Cases. Ann Surg, 2023, 277(3): 528-533. doi:10.1097/SLA.0000000000005115.
[23]	Jin R, Zheng Y, Yuan Y, et al. Robotic-assisted Versus Video-assisted Thoracoscopic Lobectomy: Short-term Results of a Randomized Clinical Trial (RVlob Trial). Ann Surg, 2022, 275(2): 295-302. doi:10.1097/SLA.0000000000004922.
[24]	Liang H, Liang W, Zhao L, et al. Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Cancer: A Meta-analysis. Ann Surg, 2018, 268(2): 254-259. doi:10.1097/SLA.0000000000002346. pmid: 28628562
[25]	Radkani P, Joshi D, Barot T, et al. Robotic video-assisted thoracoscopic lung resection for lung tumors: a community tertiary care center experience over four years. Surg Endosc, 2016, 30(2): 619-624. doi:10.1007/s00464-015-4249-z. pmid: 26091989
[26]	Khan AZ, Ali K, Khandelwal S, et al. Robotic assisted thoracoscopic right upper lobectomy for post tuberculosis aspergilloma. J Vis Surg, 2016, 2: 51. doi:10.21037/jovs.2016.02.26. pmid: 29078479
[27]	Yablonskii P, Kudriashov G, Vasilev I, et al. Robot-assisted surgery in complex treatment of the pulmonary tuberculosis. J Vis Surg, 2017, 3: 18. doi:10.21037/jovs.2016.12.09. pmid: 29078581
[28]	Khan AZ, Khanna S, Agarwal N, et al. Robotic thoracic surgery in inflammatory and infective diseases. Ann Cardiothorac Surg, 2019, 8(2): 241-249. doi:10.21037/acs.2019.02.05.
[29]	徐旭东, 叶波, 陈达, 等. 经导管动脉栓塞在结核性毁损肺胸膜全肺切除术前中的应用. 中华急诊医学杂志, 2014, 23(5):565-567. doi:10.3760/cma.j.issn.1671-0282.2014.05.023.
[30]	Chen G, Zhong FM, Xu XD, et al. Efficacy of regional arterial embolization before pleuropulmonary resection in 32 patients with tuberculosis-destroyed lung. BMC Pulm Med, 2018, 18(1): 156. doi:10.1186/s12890-018-0722-5. pmid: 30285792
[31]	Zhou YM, Song N, Lin L, et al. Application of preoperative embolization during surgery for the destroyed lung. Ann Palliat Med, 2020, 9(3): 644-647. doi:10.21037/apm.2020.04.02.
[32]	冯俊翔, 伍筱梅, 戴立果, 等. 肺叶切除术前动脉栓塞对术中出血量的影响. 影像诊断与介入放射学, 2021, 30(2): 124-129. doi:10.3969/j.issn.1005-8001.2021.02.007.
[33]	朱建坤, 刘大伟, 金锋, 等. 顽固性咯血患者肺叶切除术前行动脉栓塞介入治疗的价值. 中国防痨杂志, 2018, 40(12): 1258-1261. doi:10.3969/j.issn.1000-6621.2018.12.003.

病例编号	年龄 (岁)	性别	术式	手术时间 (min)	术中出血量(ml)	术后胸管留置时间(d)	术后住院时间(d)	术后并发症
例1	34	男	左肺上叶切除	467	160	14	15	无
例2	35	男	左肺上叶切除	395	100	10	12	无
例3	34	女	右肺上叶后段联合右肺下叶背段切除	170	30	3	4	无
例4	21	男	右肺上叶切除	70	200	7	8	无
例5	22	女	右肺上叶切除	610	100	7	8	无
例6	28	男	左肺上叶切除	295	100	5	6	无
例7	66	男	右肺上叶切除	536	200	20	22	持续漏气